Purchase Order 75F40124P00438
- Not listed
- The U.S. Food and Drug Administration (FDA) awarded an $272.4K firm fixed-price purchase order to Antibody Solutions for the production of monoclonal antibodies production clones. The contract, designated as a Total Small Business set-aside, was awarded on August 1, 2024, with an ultimate completion date of July 31, 2029. Performance will take place at the contractor's facility in Santa Clara, California. This procurement supports the FDA's regulatory and scientific mission, as monoclonal...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a $19,030.96 firm fixed-price purchase order to Epitomics Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of antibodies. The award, which was not set aside, has an ultimate completion date of April 28, 2014. This purchase order is associated with Epitomics' quote number CSQ_3719. No further details about a larger contract vehicle or...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Mabtech Inc., a Swedish biotechnology company. The $18,225.00 fixed-price contract is for the procurement of 10 units of anti-human IgG monoclonal antibody product. There is no set-aside designation for this award. Mabtech has received prior contracts from the U.S. Department of Agriculture to provide immune response assessment...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $117,000 firm fixed price delivery order against the Multiple Award Schedule to Fisher Scientific Company L.L.C. for standing orders of EXPI 293 Expression Medium 1L and Freestyle 293 Expression Media 1L. The prime contractor, a subsidiary of Thermo Electron Corporation, will deliver the requested biomanufacturing consumables from its Pittsburgh,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to EBioscience, Inc., a subsidiary of Affymetrix, Inc. The contract is for the supply of 500 milligrams of a CD 4 functional grade depletion antibody, with a ceiling value of $15,000.00. The contract was awarded on September 18, 2013, with an ultimate completion date of October 2, 2013. The contract was set aside for...
- The Defense Health Agency awarded a $20,580 firm-fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on August 26, 2025, with completion targeted for September 30, 2025. This contract procures allergen-specific immunoglobulin E (IgE) reagents essential for allergy testing and management across the San Antonio military treatment facility and 153 additional military healthcare installations. The reagent supply supports critical diagnostic capabilities...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Antibodies Incorporated, a small business manufacturer and distributor of antibodies, diagnostics, and laboratory services. The $29,292.00 contract is for the provision of KDEL receptor antibodies, which are used in biomedical research. This award was issued under a total small business set-aside solicitation, and Antibodies...
- The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services. The $6,610.00 firm fixed-price purchase order was awarded to Chondrex, Inc., a for-profit manufacturer, for the procurement of a "Monoclonal Antibody Cocktail Athrogen-CIA 100mg" with a catalog number of 53100. The award was made on December 15, 2009, with a completion date of January 13, 2010. The contract did not have...
The Food and Drug Administration's Center for Biologics Evaluation and Research awarded a $100,000 firm fixed-price purchase order to Iggenix, Inc. on September 4, 2024, for the procurement of Fel d 1-specific monoclonal antibodies. The contract calls for the delivery of 3 grams of human monoclonal antibody specific to a first epitope on the cat allergen Fel d 1 and 1 gram of biotinylated human monoclonal antibody targeting a second distinct epitope on Fel d 1. These antibodies are intended for use in enzyme-linked immunosorbent assay (ELISA) or immunoenzymetric assay (IEMA) applications. The contract was awarded with a firm fixed-price structure and no set-asides were employed in the competitive procurement process. Iggenix, Inc., located in South San Francisco, California, was selected as the prime contractor following an open competition announced on August 23, 2024, with quotes due by August 30, 2024. The award has an ultimate completion date of September 26, 2025. This procurement supports FDA's regulatory mission in biologics evaluation and research, enabling the agency to develop standardized reference materials for allergen detection and characterization purposes. No subcontractors were identified in the award documentation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA) | FDARFQ125149 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 8/23/24, 4:42 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/23/25 | |
| Not listed | Not listed | $100.0k | 9/4/24 |